Salarius Pharmaceuticals, Inc.
USD0.84
+0.19 (+29.23%)
CEO
Frederick E. Pierce
IPO Date
2015-01-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.71
Prev. Close
$0.65
Day Low
$0.69
Day High
$0.90
52W Low
$0.52
52W High
$52.95
Market Cap
$0.00B
Volume
5.96M
| -3.8 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -237.2% | -190.4% | 0.05 | 5.02 | -2.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -304.4% | -215.7% | 0.00 | 3.40 | -1.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -33.0% | -31.3% | 0.00 | 14.29 | -19.3 |
| 31 Dec 2020 | FY | 100.0% | -140.5% | -33.2% | -29.5% | 0.02 | 5.70 | -23.1 |
| 31 Dec 2019 | FY | 100.0% | -200.2% | -65.6% | -49.9% | 0.05 | 1.42 | -21.4 |
| 31 Dec 2018 | FY | 48.6% | -2615.6% | -236.2% | -211.0% | 0.00 | 2.06 | -0.3 |
| 31 Dec 2017 | FY | 60.3% | -2701.7% | -118.3% | -98.4% | 0.00 | 5.91 | -21.0 |
| 31 Dec 2016 | FY | 34.4% | -3907.6% | -66.6% | -62.5% | 0.00 | 16.06 | -26.0 |
| -0.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -20.6% | -14.3% | 0.00 | 5.49 | -6.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 115.4% | -68.8% | 0.00 | 0.92 | -6.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -2763.3% | -73.1% | 1.81 | 1.01 | -2.2 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -96.8% | -48.4% | 0.15 | 1.98 | -5.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -33.2% | -25.2% | 0.11 | 4.09 | -5.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -60.0% | -40.1% | 0.00 | 2.98 | -2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -47.0% | -35.1% | 0.03 | 3.91 | -3.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -16.7% | -13.4% | 0.05 | 5.02 | -8.7 |